Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy
NCT: NCT07680842 · RECRUITING
Brief Summary
The goal of this study is to investigate the effects of a non-invasive, low intensity focused ultrasound (LIFU) stimulation on seizure frequency and the epileptogenic network in drug-resistant epilepsy. LIFU uses focused sound waves to modulate deep brain regions and to enable changes in brain network activity. Encephalography (EEG) and behavioral tasks will also be used to study how LIFU affects brain activity.
Frequently Asked Questions
What is Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy?
Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy is a clinical trial registered under NCT07680842. Current status: RECRUITING.
What is the status of NCT07680842?
The current status of NCT07680842 (Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy) is: RECRUITING.
When did Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy start?
Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy started on 2025-07-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.